About 30% of the global population is actually overweight, and a lot of those people are seeking solutions for weight management, leading to a dramatic rise in anti-obesity medications, including GLP-1 drugs, which a projected 9% of US adults may be on by the early 2030s, Brad Schwan, VP of marketing at ADM, told FoodNavigator-USA
Semaglutide is a type of medication known as a GLP-1 receptor agonist, which is generally not recommended for use during pregnancy
A lower court dismissed the claims based on a state statute that allows for weight-loss drugs to be medicine that health plans are "not required to include." In the binding appeals court ruling, judge Ian Birk determined the regulation establishes a minimum benefit and does not address whether the exclusion is discriminatory
The most common CJC-1295 Ipamorelin side effects are brief flushing after injection, mild injection site reaction, vivid dreams during the first two weeks, occasional tingling in the hands, and mild water retention early in the cycle